- Home
- KALA vs NDLS Comparison
KALA vs NDLS Comparison
Compare KALA & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- NDLS
- Stock Information
- Founded
- KALA 2009
- NDLS 1995
- Country
- KALA United States
- NDLS United States
- Employees
- KALA N/A
- NDLS N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- NDLS Restaurants
- Sector
- KALA Health Care
- NDLS Consumer Discretionary
- Exchange
- KALA Nasdaq
- NDLS Nasdaq
- Market Cap
- KALA 26.2M
- NDLS 32.9M
- IPO Year
- KALA 2017
- NDLS 2013
- Fundamental
- Price
- KALA $5.86
- NDLS $0.92
- Analyst Decision
- KALA Strong Buy
- NDLS Strong Buy
- Analyst Count
- KALA 3
- NDLS 2
- Target Price
- KALA $14.00
- NDLS $3.00
- AVG Volume (30 Days)
- KALA 123.2K
- NDLS 224.0K
- Earning Date
- KALA 08-05-2025
- NDLS 08-06-2025
- Dividend Yield
- KALA N/A
- NDLS N/A
- EPS Growth
- KALA N/A
- NDLS N/A
- EPS
- KALA N/A
- NDLS N/A
- Revenue
- KALA N/A
- NDLS $495,670,000.00
- Revenue This Year
- KALA N/A
- NDLS $5.37
- Revenue Next Year
- KALA N/A
- NDLS $0.68
- P/E Ratio
- KALA N/A
- NDLS N/A
- Revenue Growth
- KALA N/A
- NDLS N/A
- 52 Week Low
- KALA $2.92
- NDLS $0.55
- 52 Week High
- KALA $11.20
- NDLS $1.83
- Technical
- Relative Strength Index (RSI)
- KALA 60.68
- NDLS 63.57
- Support Level
- KALA $4.36
- NDLS $0.66
- Resistance Level
- KALA $7.00
- NDLS $0.82
- Average True Range (ATR)
- KALA 0.71
- NDLS 0.09
- MACD
- KALA 0.16
- NDLS 0.03
- Stochastic Oscillator
- KALA 63.97
- NDLS 99.97
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.